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Original Article
Abstract
Purpose: To study pattern of failure, locoregional control rates (LCR) and diseasefree survival (DFS) in post-operative patients of carcinoma oral tongue, and tostudy the impact of nodal dissection on DFS in stage I and II patients. Methods: 102patients of carcinoma oral tongue treated between January 2009 and December2013 were analyzed. All patients were operated for primary disease, but neckdissection was done in 78 (76.5%) patients only. However, radiation to primarysite along with neck region was received by all patients. Pattern of failure, LCR andDFS were estimated. Results: At median follow up of 12 months, 10.8% patientsfailed locally, 10.8% in nodal region, 2.9% both at local and nodal site, and 5.9%patients failed distally. 2 year LCR and DFS was 71.2%, 90.9%, 79.5%, 0% and55.2%, 64.4%, 57.8%, 0% in stage I, II, III, IV respectively. 2 year DFS in stage Ipatients, who underwent nodal dissection and post-operative radiation (14patients) was 64.3% and in whom only neck irradiation was done (15 patients), itwas 45.8%, however difference was not significant (p = 0.5). But in stage IIpatients, 33 patients who underwent nodal dissection and post-operative radiation,2 year DFS was 85.4% and it was 21.4% in 7 patients who underwent neckradiation only, and difference showed trend towards significance (p = 0.05). 2 ormore positive lymph nodes post dissection was the only poor prognostic factor thatcorrelated with DFS (p = 0.02) Conclusion: While in stage I, neck irradiation alonecan be a possible alternative to neck dissection and post-operative radiation; forstage II, neck dissection is mandatory.
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1. IntroductionTongue cancer accounts for 25 to 40% of oral squamouscell carcinomas.1 Being a highly muscularized structureand having rich lymphatic network, tongue cancer ispredisposed for early lymph node metastasis. As such,lymph node metastasis, both occult and manifest, areobserved more commonly in oral tongue cancer than inany other cancer of the oral cavity.2 Over the years, themanagement of early stage tongue cancer (clinical tumorclassification [cT] cT1 - T2 N0 M0), has seen a majorchange, both for the primary local disease, as well as for
the neck nodes. Interstitial brachytherapy has been usedwidely for early stage disease, in place of wild localexcision or partial glossectomy, in an attempt topreserve the organ. However elective neck dissection inearly stage disease, has been a source of debate in recentyears.3, 4Spiro and Strong analyzed 314 patients (1957 - 1963) oftongue cancer, in whom neck dissection was not done,and demonstrated an overall 5-year survival rate of 42%
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only.5 Franceschi et al. in a study conducted in 297patients (1978-1987) of oral tongue cancerdemonstrated an improved overall 5-year survival rateof 65%, which was related to a more aggressivetreatment of the neck even in early tumour stages and toadjuvant radiotherapy in advanced tumour stages.6However, there is limited literature on the efficacy ofneck irradiation in controlling the occult lymph nodemetastasis from early stage carcinoma tongue, whenneck dissection has not been done. Most of the data canbe extrapolated from the survival benefits achieved bychemoradiation in patients with carcinoma oropharynx,where neck irradiation has shown results similar tonodal dissection in controlling the neck disease.7The purpose of the present study was to describe ourexperience with surgical based therapy of tongue cancerduring the last five years. Also, whether in early stagepatients (stage I and II), neck dissection can be replacedby neck irradiation or not, has been discussed.Furthermore, prognostic factors for survival wereanalyzed in order to obtain valid criteria for therapeuticdecision-making in clinical routine.
2. Methods and Materials
2.1. PatientsBetween January 2009 and December 2013, onehundred and two post-operative patients of stage I – IVA carcinoma tongue, registered and further treated atour radiation oncology department were analyzed.Patients had Karnofsky performance status > 70 andadequate haematologic (haemoglobin > 10 gm/dl,absolute neutrophil count > 1500/dl, platelets >100,000/dl), hepatic and renal function (calculatedcreatinine clearance > 60 mL/min). Exclusion criteriaincluded inoperable cases due to disease extension ormedical comorbidities, stage IV - B disease, previoustreatment with RT or chemotherapy, any prior orsynchronous malignancy, hypersensitivity to platinumagents and serious medical disease or pregnant state.
2.2. Surgery typeAll 102 patients underwent surgery for local primarydisease, wide local excision (WLE) (56 patients),hemiglossectomy (33), total glossectomy (2), WLE plussegmental mandibulectomy (10), total glossectomy plussegmental mandibulectomy (1); but only 78 (76.5%)patients out of them had underwent neck dissectionalso, for nodal control. The neck dissection done wasipsilateral (I/L) radical neck dissection (RND) in 15patients, I/L modified neck dissection (MND) in 20, I/Lsupraomohyoid neck dissection (SOND) in 32, I/L RNDplus contralateral (C/L) MND / SOND in 2 , and I/L MNDplus C/L MND/SOND in 9 patients. It is worthmentioning that in the Otolaryngology department ofour institute, all patients of early stage (I and II) oraltongue cancer are managed by elective neck dissection
along with the treatment of the primary disease. But 26patients (25.5%) already had undergone surgery forprimary disease outside the institute, and the neck wasnot addressed in 24 patients out of them (all these 24patients were early stage). Such patients when referredto our institute, are not sent for second surgery in theform of neck dissection, but are managed by electiveneck irradiation at our department of radiationoncology.Therefore, all patients irrespective of neck dissectiondone or not, were planned with local radiation toprimary as well as neck region post operatively.Indication for giving post-operative radiation in thesepatients was inadequate dissection, pathological pT2, 3,4, high risk features like poor differentiation, marginpositivity, depth of invasion > 4mm, extracapsularextension and node positivity. All the clinically nodenegative early stage (I, II) patients (T1, 2 N0 M0) whounderwent surgery for primary disease alone, weregiven elective neck irradiation, considering non neckaddressal to be inadequate surgery in these patients.
2.3. Radiation technique and dosePatients were simulated on Simulator CT (PhebusMecaserto, France) after immobilisation with athermoplastic mould and treated with either Co - 60 c -rays or 6 MV photons. Patients were treated byparallel-opposed lateral portals without any tissuecompensators. Neck nodes were treated electively in allpatients who received external radiation. Regardingdose, 40 Gy was delivered in 20 fractions in 4 weeks tothe primary and draining lymph nodes (phase I),followed by 10 Gy in 5 fractions in 1 week after sparingthe spinal cord (phase II). Additional 10 Gy in 5 fractionsin 1 week was given in the presence of high risk features.Therefore, the dose up to 50 Gy in 25 fractions was givento nodal region only in those patients, who were earlystage I and II clinically and also had pathologicallyuninvolved necks. Rest all patients were planned up to60 Gy in 30 fractions.Patients with 2 or more lymph nose positivity and thosewith extracapsular extension were planned withchemoradiation (CRT). In these patients, concurrentsingle agent cisplatin, 100 mg/m2 intravenously wasadministered on days 1, 22 and 43 of the radiationschedule after proper hydration. Radiation wasadministered within 2h after the cisplatinadministration. A complete haemogram and renalfunction tests were done before every cycle of cisplatin.Chemotherapy was withheld in cases of any grade 2 ormore haematologic or renal toxicity, till the normalvalues were recovered after specific management.
2.4. Follow upPatients were monitored for mucosal and skin reactionsat least weekly during radiotherapy. The first clinicalfollow up was scheduled at 6 weeks and thereafter every
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two months for the first year and then quarterly. ChestX-rays were obtained at 6 months intervals. Recurrenceat local or nodal site was considered as local or regionalfailure from day zero. Fine needle aspiration cytology ora biopsy was carried out to document a recurrence inclinically suspicious cases.
2.5. Statistical analysisIn this retrospective study, frequency tables with countsand percentages were used to describe pre-treatmentand treatment characteristics of the patients. Actuarialdisease free survival (DFS) and overall survival (OS)rates were calculated by the Kaplan – Meier method andstratified by stage groups. The survivals were comparedbetween early stage patients on the basis of nodaldissection, using log - rank test. Exploratory subgroupanalysis was carried out on various prognostic variables.The relationship between the clinic pathologic variablesand survival was assessed in univariate analysis usingthe log rank test. For multivariate analysis, the Coxproportional hazard model was used. A p-value of < 0.05was taken as significant. Data were analyzed using thestatistical software SPSS for windows (version 19.0).
3. Results
3.1. Patient cohort and characteristicsTable 1 shows the profile and treatment details of thetreated patients. Out of 102 patients with median age of48 years (range: 24-83 years), 29 (28.4%) patients werestage I, 40 (39.2%) were stage II, 25 (24.5%) were stageIII, and 8 (7.8%) were stage IVa. 74.5% of the totalpatients were operated at our institute, rest wereoperated outside. All 102 patients underwent surgeryfor local primary disease, but only 78 (76.5%) patientsout of them had underwent neck dissection also, fornodal control. All patients however had receivedpostoperative radiation to the primary as well as neckregion.
3.2. Early stage, clinically node negative, but
pathologically node positiveOut of 29 stage I patients, only 1 (3.4%) waspathologically node positive, but out of 40 stage IIpatients, 16 out of 33 patients who underwent neckdissection (40% of stage II) were pathologically nodepositive. This clearly indicates the definite need for neckaddressal even in early stage patients. Table 2 shows thepostoperative histopathological features among thepatients.
3.3. Adjuvant treatmentPost operatively, 78 (76.4%) patients were treated byexternal beam radiation therapy and 22 (20.6%)patients received chemoradiation. Rest 2 (2%) patientswere treated with radiation and brachytherapy boost.
3.4. Pattern of failureAt 12 month median follow up period, 31 (30.4%)patients failed. Table 3 shows the pattern of failureamong these patients and the stage to which theybelong.
Table 1: Patients’ profile and treatment details.Characteristics Number of patients (percentage)GenderMaleFemale 73 (71.6%)29 (28.4%)Age(years)MedianRange 4824 – 83Tumor lateralityRightLeftTip 51 (50%)48 (47%)3 (3%)T stageT1T2T3T4a
33 (32.4%)49 (48%)15 (14.7%)5 (4.9%)N stageN0N1N2a 83 (81.4%)15 (14.7%)4 (3.9%)TNM stageIIIIIIIVa
29 (28.4%)40 (39.2%)25 (7.8%)8 (7.8%)
TreatmentSx ---> RTSx--->RT + BTSx --->CRT 78 (76.4%)2 (2%)22 (21.6%)Sx placeOur instituteOutside 76 (74.5%)26 (25.5%)Sx typeWLEHemiglossectomyTotal glossectomyWLE + segmentalmandibulectomyTotal glossectomy+ segmentalmandibulectomy
56 (55.4%)33 (32.4%)2 (2%)10 (9.8%)1 (1%)
Neck dissectionYesNo 78 (76.5%)24 (23.5%)Type of neckdissectionI/L RNDI/L MNDI/L SONDI/L RND +C/LMND/SONDI/L MND + C/LMND/SOND
15 (14.7%)20 (19.6%)32 (31.4%)2 (2%)9 (8.8%)
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Table 2: Patients’ post-operative histopathological detail.Characteristics Number of patients(percentage)HistopathologySquamous cell carcinomaAdenocarcinomaNo residual 100 (98%)1 (1%)1 (1%)DifferentiationWellModeratelyPoorly 70 (68.6%)29 (28.4%)2 (2%)Depth of invasion>4 mmYesNo 65 (63.7%)36 (35.3%)Superior marginInvolvedfree 1 (1%)100 (98%)Inferior marginInvolvedFreeclose 13 (12.7%)79 (77.5%)9 (8.8%)Anterior marginInvolvedFreeclose 1 (1%)94 (94.1%)4 (3.9%)Posterior marginInvolvedFreeclose 4 (3.9%)94 (92.2%)3 (2.9%)Medial marginInvolvedFreeClose 6 (5.9%)92 (90.2%)3 (2.9%Lateral marginInvolvedFreeClose 2 (2%)98 (96.1%)1 (1%)Margin positivityInvolvedFree 19 (18.6%)83 (81.4%)LVIInvolvedFree 8 (7.8%)93 (91.2%)ECEPresentAbsent 8 (7.8%)93 (91.2%)Number of positive LN0123 or moreNodal status according tostage
47 (46.1%)14 (13.7%)5 (4.9%)12 (11.8%)
T1: Clinically N0, but pN+T2: Clinically N0, but pN+ 1 out of 29 (3.4%)16 out of 40 (40%)
Table 3: Pattern of failure.Failure type Number ofpatients(percentage) Stage wise failuresStage(Number of patientsfailed)Local 11 (10.8%) I (7)II (1)III (1)IV (2)Lymph nodal 11 (10.8%) I (2)II (5)III (4)Local +lymphnode 6 (5.9%) I (2)II (1)III (3)Distant 3 (2.9%) I  (1)II (2)Loco - regional control rates and survival rates (Figure1a, 1b, 1c, 1d, 1e)2-year overall Local control (LC) rate combined for allstages was 71.9%, nodal control rate was 69.2%, DFSwas 55.3% and OS was 59.1 %.The Kaplan – Meier estimate yielded 2-year LC rate of71.2%, 90.9%, 79.5% and 0% in stage I, II, III and IVrespectively. 2 year DFS for stage I, II, III and IV was55.2%, 64.4%, 57.8% and 0% respectively. The OS forstage I, II, III and IV was 63.9%, 66.4%, 53% and 0%respectively.
Figure 1a: 2-year Local control rate.
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Figure 1b: 2-year Nodal control rate.
Figure 1c: 2-year Disease free survival.
Figure 1d: 2 year Overall survival.
Figure 1e: Stage wise 2-year disease free survival.Nodal failure rate and DFS in stage I patients based onnodal dissection (Figure 2a, 2b)As shown in table 4, the 2 year nodal failure rate in stageI patients who underwent neck dissection, were pN0 andunderwent postoperative radiation [14 patients] was17.5% , and it was 37.5% in those stage I patients inwhom no neck dissection was done, but neck irradiationwas done [15 patients]) (p = 0.4; HR - 0.46, 95%CI-0.07-2.79). The 2-year DFS in stage I patients was64.3% (who underwent neck dissection andpost-operative radiation) and 45.8% (in whom no neckdissection, but neck irradiation was done) (p = 0.5; HR -0.66, 95% CI - 0.19 - 2.28). This indicated that there is adefinite need for neck addressal in stage I patients.However, the results with neck radiation alone are notstatistically different from neck dissection plus neckirradiation.
Figure 2a: Disease free survival in stage I patients based onneck dissection.
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Figure 2b: Nodal control rate in stage I patients based onneck dissection.
Nodal failure rate and DFS in stage II patients based onnodal dissection (Figure 3a, 3b)As shown in table 5, the 2 year nodal failure rate in stageII patients who underwent neck dissection, were pN0and underwent postoperative radiation [33 patients]was 14.6% , and it was 71.4% in those stage II patientsin whom no neck dissection was done, but neckirradiation was done [7 patients]) (p = 0.1; HR - 0.29,95% CI - 0.05 - 1.46). The 2 year DFS in stage II patientswas 85.4% (who underwent neck dissection andpost-operative radiation) and 21.4% (in whom no neckdissection, but neck irradiation was done) (p = 0.05; HR -0.23, 95% CI - 0.05 - 1.03). This indicates that neckdissection is mandatory in stage II patients, and neckirradiation alone cannot be an alternative to neckdissection in stage II patients.
Table 4: Outcome in stage I patients based on nodal dissection plus radiation versus only radiation.Nodes dissectedPathological node negative (pN0)Post-operative radiation given Nodes not dissectedClinical node negative (cN0)Radiation given P-value2 year nodal failure rate 2 out of 14 (17.5 %) 5 out of 15 (37.5 %) 0.42 year DFS 9 out of 14 (64.3 %) 7 out of 15 (45.8 %) 0.5
Table 5: Outcome in stage II patients based on nodal dissection plus radiation versus only radiation.Nodes dissectedPathological node negative (pN0)Post-operative radiation given Nodes not dissectedClinical node negative (cN0)Radiation given P-value2 year nodal failure rate 5 out of 33 (14.6 %) 5 out of 7 (71.4 %) 0.12 year DFS 28 out of 33 (85.4%) 2 out of 7 (21.4 %) 0.05
Figure 3a: Disease free survival in stage II patients basedon neck dissection.
Figure 3b: Nodal control rate in stage II patients based onneck dissection.
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3.5. Prognostic factors for survivalIn univariate analysis (log rank), the p N status (p =0.07) and neck dissection (p = 0.08) showed trendtowards significance, and were identified as prognosticfactors for disease free survival after treatment. Tumoursite (p = 0.0.81), pT - status (p = 0.31), stage (p = 0.55),grading (p = 0.38), depth of invasion > 4mm (p = 0.80),number of lymph node metastases > 2 (p = 0.25),extracapsular spread (p = 0.67) and clear margins (p =0.64) did not show significant values.However, p N status was significantly correlated tonodal disease free survival in the univariate analysis (p =0.03). However, in multivariate analysis (Coxproportional hazard model), the only variable which hadsignificant correlation to the disease free survival wasthe number of positive lymph nodes > 2 post dissection(p = 0.02).
3.6. Attempt for salvage therapyAll recurrences were verified histologically, unlessobvious by clinical examination. In patients withresidual tumour, disease recurrence, or progression ofdisease, salvage surgery or palliative treatment wasoffered, depending on the status of the individualpatient, their symptoms and previous treatment.Among the 11 local recurrences, 6 patients wereplanned for total glossectomy, but only 4 underwent thesame (3 patients out of these also received radiationpost surgery) and rest were lost to follow up. 5 patientswere planned for palliative chemotherapy, but only 1could receive the same, rest were lost to follow up.Among the 11 patients who had isolated nodal failures, 2patients underwent radical neck dissection, 4 patientswho either already had neck dissection or hadinoperable lymph node relapse, received radiation (withor without chemotherapy), 1 patient was planned withpalliative chemotherapy and rest were lost to follow up.Out of 6 patients who had both local and lymph noderelapse, only 2 received palliative chemotherapy, andrest were suitable for best supportive care only. Out of 3patients with distant relapse, only one receivedpalliative chemotherapy, 2 others were given bestsupportive care.
4. DiscussionTongue is the most common subsite for squamous cellcarcinoma of oral cavity, accounting for 25 – 40% oftotal oral cancers.1 Among the total cases of carcinomaoral tongue, 30% are early stage and nearly 70% areadvanced stage.2,3 Despite the development ofmultimodal treatment options, the prognosis remainsrelatively poor.
In a retrospective study, conducted by Kokemueller in341 patients with squamous cell carcinoma of thetongue, between 1980 and 2009, it was found that localand regional failures occurred in 23.9% and 20.4%patients respectively, leading to a total failure rate of37.2% after an average duration of 1.6 years.8N - Status,extracapsular spread and clear margins were identifiedas the dominant factors for survival, which wascalculated to be 54.5% after 5 years.Almangush et al. analyzed 479 patients with early-stage(cT1 - 2N0) oral tongue squamous cell cancer.9 Depth ofinvasion (DOI) and worst pattern of invasion (WPOI)were the strongest pathological predictors forlocoregional recurrence, with a hazard ratio for 4 mmDOI of 1.67 (95% confidence interval (CI) 1.07 – 2.60)and HR for WPOI of 1.46 (95% CI 0.95 – 2.25). Inaddition, mortality was also predicted by DOI (HR 2.44,95% CI 1.34 – 4.47) and by WPOI (HR 2.34, 95% CI 1.26– 4.32). The study suggested that clinically early-stageoral tongue carcinomas 4 mm or deeper, or with agrowth pattern of small cell islands or satellites, shouldbe considered as high - risk tumors which requiremultimodality treatment. Review of thirteenretrospective studies by Andres et al. to address the roleof adjuvant radiotherapy for patients with perineuralinvasion, showed that large nerve or multifocalperineural invasion may predict worse outcome andmay be a more appropriate indication for adjuvanttherapy.10In our study, pN status (p = 0.07) and neck dissection (p= 0.08) showed trend towards significance in univariateanalysis (log rank), and were identified as prognosticfactors for disease free survival. p N status was alsosignificantly correlated to nodal disease free survival inthe univariate analysis (p = 0.03). In multivariateanalysis, the only variable which had significantcorrelation to the disease free survival was the numberof positive lymph nodes > 2 post dissection (p = 0.02)The overall locoregional recurrence rates as describedby the studies in literature range between 16 and 42%.11
– 16 But in our study, stage I patients had higher localrecurrences after wide local excisions, as compared tothe other stages, which is unusual. It was found out thatall these patients had undergone surgery for the primarydisease from outside the institute. Therefore thecomment could not be made on the adequacy ofdissection. This is also the reason why overall localcontrol rates and disease free survivals are lesser instage I compared to stage II. Similarly, the overallsurvival rate of our patients with tongue cancer is lesserthan the survival rates described by other authors,which are quoted between 40 and 65%.5, 6, 17Early stage carcinoma tongue patients (T1 T2 N0M0)generally have good survival. Ganly et al. showed that5-year disease - specific and overall survival rate was
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86% and 79% respectively.18 The management for suchpatients includes treatment for the primary site and thatof the cervical lymph nodes. For the treatment ofprimary local site, surgery and brachytherapy are thewidely used options. However, the management ofpatients with clinically negative nodes (N0) with earlytongue cancer is controversial. There has been a debatewhether such patients should be kept on follow up orshould undergo elective neck dissection or only localradiation to neck without neck dissection would suffice.Those who favor wait and watch policy argue that 80%of patients with N0 neck would be over treated, andsubjected to additional morbidity and costs. Weiss et al.suggested that elective neck dissection is necessary ifthe incidence of occult metastasis is greater than 20%.19It is generally accepted that cancer of the oral tongueoften shows lymph node involvement even in earlystages .The proportion of occult metastases is quotedbetween 24 and 42%.20, 21, 22 Even in our study, 40% ofthe stage II patients who were clinically node negative,were found to be pathologically node positive after neckdissection.Two randomized controlled trials (RCTs) performed tocompare elective neck dissection with observationalone, did not find any survival difference between thetwo arms and tumor depth of > 4 mm was associatedwith higher rates of involved nodes and suggested thatthese set of patients may benefit from elective neckdissection.23,24 However, both these RCTs had smallnumbers and consisted of methodology flaws, so theirresults could not be applied clinically.In our part of the world, where patient compliance forfollow up is poor, “wait and watch” policy for early stagecarcinoma tongue patients (operated for primary alone),can be disastrous. Therefore, all these patients are takenup for post-operative radiation to primary and neck atour institute.Till date, there is no study in literature which hasprospectively compared elective neck dissection to neckirradiation alone in early stage patients of carcinomatongue. However there are some retrospective studieswhich have analyzed the role of post-operativeradiotherapy pT1 - T2 N0 deep tongue cancers.Gokavarapu et al. analyzed 103 patients primary pT1 -T2 N0 oral tongue cancer of depth of invasion 4 mm orgreater treated surgically from January 2010 toDecember 2012.25 62 patients received post-operativeradiotherapy (PORT) and 41 patients did not receive thesame; median period of follow - up was 41.3 months.Logistic and Cox regression models showed nosignificant difference in locoregional recurrences (P =.078) and survival (P = 0.339) between patients whoreceived PORT and those who did not receive PORT.In the present study also, no significant impact of depthof invasion was found on the loco - regional recurrences
and survival. However, by determining stage wise loco -regional and disease free survival rates, the presentstudy was able to find out whether neck irradiationalone could replace the elective neck dissection andpostoperative radiation in early stage I and II carcinomatongue patients.Our results show that out of 29 clinically node negativestage I patients, only 1 was pathologically positive. The 2year disease - free survival in stage I post-operativepatients of carcinoma tongue, who underwent nodaldissection and post-operative radiation was 64.3% andin those in whom nodal dissection was not done, butradiation was given, it was 45.8%, and the differencewas not statistically significant (p = 0.5). This indicatesthat neck addressal is mandatory, however neckirradiation can be considered as an alternative to neckdissection for stage I patients of carcinoma tongue. Butfor stage II patients, it was found that 2 year DFS washigher in patients who had undergone neck dissectionand post-operative radiotherapy, compared to neckirradiation alone, and p value of 0.05 shows trendtowards significance.However, the basic limitation of this study is that thisearly stage carcinoma tongue group of patients does notrepresent the entire early stage carcinoma tonguepatients being treated at our institute. There are somepatients with stage T1 N0M0 who underwent surgeryfor local primary with or without neck dissection underotolaryngology department, and the histopathologybeing favorable, were kept on follow up, and hence werenot accessible for the present study. Therefore, withoutanalyzing that subgroup of early stage carcinoma tonguepatients, it is difficult to inculcate these conclusions intoclinical practice.Also, by analyzing all above stage I post-operativepatients (who were kept on follow up in view offavorable histology, and were not accessible for thepresent study), it would have been possible to comparethe outcomes of neck irradiation alone to neckdissection alone. Therefore, a large well-randomizedstudy is needed before clinically applying the results onthe patient population.
5. ConclusionTo conclude, in early stage patients of carcinoma tongue,along with the management of local primary site, theneck should also be addressed, as the outcomes aresignificantly improved after primary surgical resectionwith concomitant neck dissection.3,4,6 And based on ourstudy, we conclude that elective neck irradiation can beconsidered as an alternative to neck dissection plusradiation to treat occult lymph node metastasis in stage Icarcinoma oral tongue, but the same does not hold truefor stage II patients in which neck dissection ismandatory.
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